echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Pharmaceutical Marketing > Anhui released the 2021 White Paper on the Safety Status of Drugs and Medical Devices

    Anhui released the 2021 White Paper on the Safety Status of Drugs and Medical Devices

    • Last Update: 2023-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the Anhui Provincial Food and Drug Administration released the white paper "Anhui Province Drug and Medical Device Safety Status (2021)" (hereinafter referred to as the white paper).

    According to the white paper, in 2021, the Anhui Provincial Food and Drug Administration fully implemented the "Drug Safety Benchmarking and Improvement Action" to promote the stability and improvement of the drug safety situation in the province, serve the high-quality development of the pharmaceutical industry effectively and effectively, and achieve a good start in drug supervision in the 14th Five-Year Plan
    .
     
    The White Paper pointed out that in 2021, Anhui Province made a major breakthrough
    in the supervision of anti-epidemic drugs and devices.
    The supervision of the production of new coronavirus vaccines has been rapidly improved and gradually standardized from scratch; Establish a three-level coordination and promotion mechanism for the batch issuance of new coronavirus vaccines by the provincial government, the provincial food and drug administration, and the provincial food and drug inspection institute, obtain the national authorization for the batch issuance of recombinant new coronavirus vaccines, and complete 490 batches of new coronavirus vaccine main inspection and co-inspection without error and no overdue; Achieve full coverage inspection of 8 vaccine distribution enterprises, 114 disease control institutions and 2,654 new coronavirus vaccination sites in the province
    .
     
    While the regulatory system and standard system are more perfect, and the risk monitoring and disposal are strong and effective, the Anhui Provincial Food and Drug Administration has achieved outstanding
    results in supervision in key areas.
    Vigorously carry out special inspections such as the production and operation of stimulant-containing drugs, selected drugs in the national centralized procurement, the production of traditional Chinese medicines, and the circulation of drugs, and organize and carry out special actions
    such as the "Spring Wind Action for Drug Safety", the action to improve the quality of Chinese medicine pieces, the investigation and management of hidden dangers of medical devices, and the special treatment of "two products and one device" in Internet sales.
    A total of 3,778 illegal cases of drugs and devices were investigated and dealt with throughout the year, effectively deterring illegal and criminal acts
    .
     
    In addition, the capacity building of drug supervision in Anhui Province has been accelerated, and the implementation of three major projects
    of "double hundred" introduction, "leading geese" and capacity improvement has been launched.
    Serving the development of the pharmaceutical industry has achieved remarkable results, and the "Anhui Province Class II Medical Device Priority Approval Measures" has been promulgated, and the average approval time limit for various approval matters has been reduced to 43.
    6%
    of the statutory time limit.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.